Mise à niveau vers Pro

Bioburden Testing Market Outlook, Size, Value Share, Industry Segment and Forecast to 2030

Bioburden Testing Market

Bioburden testing refers to an estimation of microbial load on a medical instrument, raw material, packaged goods among others. Several factors such as rising medical spending, increasing food safety concerns and growing product recalls due to microbial contamination are projected to drive the growth of the market.

The Bioburden Testing Market Share is expected to grow at a rate of roughly 13% between 2022 and 2030.

Bioburden testing is carried out to limit the chances of any microbial contamination in a non-sterile product. Increasing food safety concerns is among a key factor supporting the growth of the market. Rise in a number of product recalls due to microbial contamination, food & beverage manufacturers are directing their focus towards prevention of contamination. The US FDA has mandated enactment of food safety measures for protecting consumer health which has further generated demand for bioburden testing.

Bioburden testing is standard in quality control of medical devices to ensure suitability of the devices which fosters the growth of the global bioburden testing market. Surging cases of sterility failures, raw material contamination, and requirement to ensure compliance with stringent FDA regulations pertaining to medical device testing has generated demand for bioburden testing.  

Test methods and specifications outlined by federal agencies of numerous countries suggest performing bioburden testing to ensure the viability of the volume of microorganisms present in pharmaceutical products. This can positively affect market prospects.

Bioburden Testing Market Outlook and Analysis By Test Type (Aerobic Count, Anaerobic Count, and others), by Product Type (Consumables, Instruments), by Application (Raw Materials Testing, Medical Devices Testing, and others), by End-User - Forecast Till 2030

However, bioburden testing procedures are time, labor and space intensive which might restrain the growth of the market. The high cost of microbial enumeration instruments is also a hindrance to the market. Lack of uniform international standards might also curb the growth of the market.  However, the development of more efficient bioburden testing procedures has contributed to the growth of the market.

Major Key Players:

Some of Key Market Players are WuXi AppTec, Charles River, SGS SA, Merck KGaA, NORTH AMERICAN SCIENCE ASSOCIATES INC., Becton, Dickinson, and Company, Nelson Laboratories, LLC, Pacific Biolabs, ATS Laboratories, Inc., and Dynatec Labs.

Segment Analysis

The global bioburden testing market has been segmented into test type, product type, application and end-user.

The market, on the basis of type, has been segmented into aerobic count, anaerobic count, fungi count and spore count.

The market, on the basis of product type, has been segmented into consumables and instruments.

The market, by consumables, has been sub-segmented into reagents and kits, and others.

The bioburden testing medical devices, has been further segmented into polymerase chain reaction machine (PCR), microscopes, and others.

The market, by application, has been segmented into raw materials testing, medical devices testing, in-process material testing, sterilization validation testing, and equipment cleaning validation.

The market, by end-user, has been segmented into pharmaceutical and biotechnology companies, microbial testing laboratories, and others.

Regional Analysis

The market in the Americas is expected to dominate the global bioburden testing market during the forecast period owing to the presence of well-established healthcare system, increasing healthcare expenditure, and favorable reimbursement scenario. The European market is expected to be the second-largest due to availability of funds for research from public and private sources. Moreover, the market in Asia-Pacific is predicted to be the fastest-growing during the assessment period owing to growing disposable income, and continuously developing economies. The market in the Middle East & Africa is likely to account for the smallest share of the global bioburden testing market. The market growth in this region can be attributed to the growing government initiatives.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com